Pharmaceuticals, Biotechnology and Life Sciences
COOKEVILLE, Tenn.–(BUSINESS WIRE)–Aphena Pharma Solutions Inc. today announced that it has approved $7 million for company-wide expansion for future growth…
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced…
PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today…
AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research, an integrated research organization (IRO), announces the launch of its innovative IntElligo Research Stack™ clinical…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the RBC Capital Markets 2019 Global Healthcare…
– Initiated pivotal study of livoletide in Prader-Willi syndrome (PWS) – – Established foundation for a commercial organization in Boston…
HYDERABAD, India & LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRDO?src=hash" target="_blank"gt;#CRDOlt;/agt;–GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one…
BLACKSBURG, Va.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Crohns?src=hash" target="_blank"gt;#Crohnslt;/agt;–Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class, oral…
Study achieves all co-primary and secondary endpoints NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a…
Commercial Study Will Measure Impact of Increasing Access and Affordability of Aesthetic Procedures IRVINE, Calif.–(BUSINESS WIRE)–PatientFi, LLC, a leading financial…